These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12181031)

  • 21. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Koczwara B; Spangenthal E; Bernstein SH
    Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission.
    Girardi K; Paviglianiti A; Cirillo M; Bianchi A; Gherardi G; Annibali O; Cerchiara E; Marchesi F; Tomarchio V; Miglio C; Tirindelli M; Onetti Muda A; Avvisati G
    J Clin Exp Hematop; 2012; 52(1):31-4. PubMed ID: 22706528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Criteria for use of cladribine in adults.
    Fedak MN
    Am J Hosp Pharm; 1994 Sep; 51(17):2185-6. PubMed ID: 7985700
    [No Abstract]   [Full Text] [Related]  

  • 25. Cladribine (Leustatin). Single-dose treatment for leukemia.
    Am J Nurs; 1994 Nov; 94(11):59-60. PubMed ID: 7977509
    [No Abstract]   [Full Text] [Related]  

  • 26. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
    Strupp C; Fenk R; Kündgen A; Gattermann N; Haas R; Germing U
    Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine.
    Juarez M; Marshall R; Denton C; Evely R
    Rheumatology (Oxford); 2008 Nov; 47(11):1734-5. PubMed ID: 18812428
    [No Abstract]   [Full Text] [Related]  

  • 29. Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia.
    Sarmiento MA; Neme D; Fornari MC; Bengió RM
    Leuk Lymphoma; 2000 Nov; 39(5-6):657-9. PubMed ID: 11342351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse osteosclerosis complicating hairy cell leukemia.
    Leung R; Lopes D; Lam C; Wong KF; Kung AW; Kwong YL
    J Clin Oncol; 2010 May; 28(13):e203-4. PubMed ID: 20194859
    [No Abstract]   [Full Text] [Related]  

  • 31. Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature.
    Broccoli A; Gandolfi L; Pellegrini C; Agostinelli C; Argnani L; Zinzani PL
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 27002952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
    Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T
    Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.
    Ganzel C; Gatt ME; Maly A; Ben-Yehuda D; Goldschmidt N
    Leuk Lymphoma; 2012 Jun; 53(6):1169-73. PubMed ID: 22035415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder stones formation eight months after treatment of hairy-cell leukemia with 2-chloro-deoxyadenosine: a case report.
    Bessa O
    Conn Med; 1995 Jun; 59(6):331. PubMed ID: 7648851
    [No Abstract]   [Full Text] [Related]  

  • 36. Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine.
    Robak T; Błasińska-Morawiec M; Krykowski E
    Acta Haematol Pol; 1992; 23(4):285-90. PubMed ID: 1363455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hairy cell leukaemia (HCL) with 2-chlorodeoxyadenosine (2-CdA): identification of parameters predictive of adverse effects.
    Legrand O; Vekhoff A; Marie JP; Zittoun R; Delmer A
    Br J Haematol; 1997 Oct; 99(1):165-7. PubMed ID: 9359518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular manifestation of hairy cell leukemia with dramatic response to 2-chloro-deoxy-adenosine.
    Robinson A; Eting E; Zeidman A; Djaldetti M; Mittelman M; Savir H
    Am J Ophthalmol; 1996 Jan; 121(1):97-9. PubMed ID: 8554090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of one hairy cell leukemia case with single course of cladribine].
    Zhang LJ; Qiu HX; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):336. PubMed ID: 21729604
    [No Abstract]   [Full Text] [Related]  

  • 40. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.